Home Telesis Bio

Telesis Bio

In operation
IPO
Synthetic Biology Solutions Provider

Basic Information

In March 2020, SGI-DNA, Inc. was renamed Codex DNA, Inc. On January 4, 2023, Codex DNA, Inc. was renamed Telesis Bio, Inc.Telesis Bio provides researchers with end-to-end solutions and tools that enable them to design, code, and create synthetic DNA quickly and safely, increasing productivity in the product development cycle by up to 20 times. As the creator of the BioXp™ system (the world's only synthetic biology workstation) and the industry-standard Gibson Assembly® method, Telesis Bio offers comprehensive end-to-end solutions for synthetic biology workflows. Telesis Bio, Inc. is accelerating advancements in the following areas: personalized medicine, biologic drug discovery, vaccine development, genomic editing, and cell and gene therapy.
Telesis Bio, Inc.
SanDiego,California,United States of America
101~500 people
January 01, 2013
hello@codexdna.com